Orexigen Therapeutics, Inc. (NASDAQ:OREX) Basic Net EPS Stands At $-5.2

0

Orexigen Therapeutics, Inc. (NASDAQ:OREX) had an annual basic consolidated EPS of $-5.2381 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $-5.2381.

EPS from continuing operations

Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported $-5.2381 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $-5.2381 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Orexigen Therapeutics, Inc. (NASDAQ:OREX) received basic EPS of $-5.2381 for the annual period ended 2015-12-31. EPS contribution from the parent company was $-5.2381 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $-5.2 was reported by Orexigen Therapeutics, Inc. (NASDAQ:OREX) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $-5.2.

Consolidated diluted EPS

For the period ended 2015-12-31, $-5.2381 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $-5.2381 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $-5.2381 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $-5.2381 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $-5.2 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $-5.2.

Diluted EPS from parent

Diluted EPS of $-5.2381 was received by Orexigen Therapeutics, Inc. (NASDAQ:OREX) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $-5.2381 on quarterly basis. For the annual period ended 2015-12-31, $-5.2 was posted by Orexigen Therapeutics, Inc. (NASDAQ:OREX) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $-5.2 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 13.113. But it was 13.113 for the quarter ended 2015-12-31. 13.113 and 13.113 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 23 times, 1 visits today)